创伤过渡期护理协调:一个成熟运行中的系统
本研究报道了一个护士主导的创伤过渡期护理协调(TTCC)项目的成熟运行效果。2014年1月至2016年9月共纳入475例高危创伤患者,73%损伤严重度评分为3或4级。TTCC干预包括出院72小时内电话随访、完整药物核对、医疗预约协调和个体化问题解决。与未接受TTCC者相比,下肢损伤、复杂气管切开和肠道手术患者的30天再入院率分别降低6个百分点(10% vs 16%,p=0.05)、11个百分点(13% vs 24%,p=0.05)和16个百分点(11% vs 27%,p=0.05)。作者认为针对高危患者的定向门诊支持可降低30天再入院率,并通过质量付费每年为医院节省超过100万美元。
要点
- TTCC项目纳入高危创伤患者,干预包括出院72小时内电话随访、完整药物核对、预约协调和个体化问题解决。
- 475例TTCC入组者中73%损伤严重度评分为3或4级(最高4级),54.5%为Medicaid、13.5%为Medicare、仅10.5%有私人保险。
- 下肢损伤患者接受TTCC后30天再入院率10% vs 未接受者16%,降低6个百分点(p=0.05)。
- 复杂气管切开患者接受TTCC后30天再入院率13% vs 未接受者24%,降低11个百分点(p=0.05)。
- 肠道手术患者接受TTCC后30天再入院率11% vs 未接受者27%,降低16个百分点(p=0.05)。
适用人群与场景
- 高危创伤患者,TTCC项目入组标准为高30天再入院风险者。
- 475例入组者中73%的损伤严重度评分为3或4级(最高严重度评分为4级)。
- 入组者保险构成:私人保险10.5%(n=50)、Medicaid 54.5%(n=259)、Medicare 13.5%(n=64)。
- 最常见All Patient Refined Diagnosis Related Groups:下肢操作(n=67,14%)、广泛腹部/胸部操作(n=40,8.4%)、肌肉骨骼操作(n=37,7.8%)、复杂气管切开和上肢操作(各n=29,6.1%)、感染性疾病并发症(n=14,2.9%)、主要胸部/呼吸创伤、主要小肠和大肠操作及血管操作(各n=13,2.7%)。
处置流程与药物剂量
- TTCC为护士主导项目,干预包括出院72小时内电话联系患者。
- TTCC干预包括完整药物核对。
- TTCC干预包括协调医疗预约。
- TTCC干预包括个体化问题解决。
研究设计与关键结果
- 研究类型为项目评估,2014年1月至2016年9月共纳入475例患者。
- 通过Account ID将TTCC患者与Health Services Cost Review Commission数据库链接,收集全州非计划30天再入院数据。
- 下肢损伤患者接受TTCC者30天再入院率10% vs 未接受TTCC者16%,降低6个百分点(p=0.05)。
- 复杂气管切开患者接受TTCC者30天再入院率13% vs 未接受TTCC者24%,降低11个百分点(p=0.05)。
- 肠道手术患者接受TTCC者30天再入院率11% vs 未接受TTCC者27%,降低16个百分点(p=0.05)。
- 作者报告该项目通过质量付费每年为医院节省超过100万美元。
证据类型、等级与局限
- 证据类型:治疗/护理管理研究,证据等级III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为针对高危患者的定向门诊支持可降低30天再入院率。
- 作者报告随着TTCC项目成熟,下肢损伤、复杂气管切开和肠道手术患者的30天再入院率降低。
- 作者报告该项目通过质量付费每年为医院节省超过100万美元。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: We have previously demonstrated effectiveness of a Trauma Transitional Care Coordination (TTCC) Program in reducing 30-day readmission rates for trauma patients most at risk. With program maturation, we achieved improved readmission rates for specific patient populations.
METHODS: TTCC is a nursing driven program that supports patients at high risk for 30-day readmission. The TTCC interventions include calls to patients within 72 hours of discharge, complete medication reconciliation, coordination of medical appointments, and individualized problem solving. Account IDs were used to link TTCC patients with the Health Services Cost Review Commission database to collect data on statewide unplanned 30-day readmissions.
RESULTS: Four hundred seventy-five patients were enrolled in the TTCC program from January 2014 to September 2016. Only 10.5% (n = 50) of TTCC enrollees were privately insured, 54.5% had Medicaid (n = 259), and 13.5% had Medicare (n = 64). Seventy-three percent had Health Services Cost Review Commission severity of injury ratings of 3 or 4 (maximum severity of injury = 4). The most common All Patient Refined Diagnosis Related Groups for participants were: lower-extremity procedures (n = 67, 14%); extensive abdominal/thoracic procedures (n = 40, 8.4%); musculoskeletal procedures (n = 37, 7.8%); complicated tracheostomy and upper extremity procedures (n = 29 each, 6.1%); infectious disease complications (n = 14, 2.9%); major chest/respiratory trauma, major small and large bowel procedures and vascular procedures (n = 13 each, 2.7%). The TTCC participants with lower-extremity injury, complicated tracheostomy, and bowel procedures had 6-point reduction (10% vs. 16%, p = 0.05), 11-point reduction (13% vs. 24%, p = 0.05), and 16-point reduction (11% vs. 27%, p = 0.05) in 30-day readmission rates, respectively, compared to those without TTCC.
CONCLUSION: Targeted outpatient support for high-risk patients can decrease 30-day readmission rates. As our TTCC program matured, we reduced 30-day readmission in patients with lower-extremity injury, complicated tracheostomy and bowel procedures. This represents over one million-dollar savings for the hospital per year through quality-based reimbursement.
LEVEL OF EVIDENCE: Therapeutic/care management, level III.
参考来源
- Hall EC, Tyrrell RL, Doyle KE, et al. Trauma transitional care coordination: A mature system at work. J Trauma Acute Care Surg. 2018. PMID: 29370060. doi:10.1097/TA.0000000000001818
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。